Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: Comparison with transarterial chemoembolisation monotherapy - Preliminary observations

British Journal of Radiology

Volumn 85, Issue 1018, 2012, Pages

  Kim, J ^a   Chung, Dong Jin ^a   Jung, S E ^b   Cho, S H ^a   Hahn, S T ^a   Lee, J M ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84866853430     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/32750755     Document Type: Article

References (15)

1. Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2005) and survival (1993-2005) in Korea. Seoul, Republic of Korea: Ministry for Health, Welfare and Family Affairs; 2008.
2. Korean National Statistical Office. Annual report on the cause of death statistics. Seoul, Republic of Korea: Korean National Statistical Office; 2009.
3. Park KW, Park JW, Kim TH, Choi JI, Kim SH, Park HS, et al. Five-year survival analysis of a cohort of hepatocellular carcinoma patients who were treated at the National Cancer Center, Korea. Korean J Hepatol 2007;13:530-42.
4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9. (Pubitemid 26079803)
5. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373-82. (Pubitemid 34183888)
6. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-42. (Pubitemid 36152543)
7. Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005;11:6104-9. (Pubitemid 43085049)
8. Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008;247:260-6.
9. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al. Advanced hepatocellular carcinoma: treatment with highintensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005;235:659-67. (Pubitemid 40571111)
10. Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. Eur J Cancer 2010;46: 2513-21.
11. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005;5:321-7. (Pubitemid 40488637)
12. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol 2008;190: 191-9.
13. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52-60.
14. Li YY, Sha WH, Zhou YJ, Nie YQ. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:2148-54.
15. Zhang L, Zhu H, Jin C, Zhou K, Li K, Su H, et al. Highintensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 2009;19:437-45.